Simultaneously, tumor-derived exosomes containing oncogenic factors activate NF-κB in stromal cells, reprogramming them toward pro-tumorigenic phenotypes, such as CAFs (Paggetti et al., 2015). This evidence concerns the gene NFKB1 and neoplasm.